← All indications
HELLP Syndrome
A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count (THROMBOCYTOPENIA). HELLP syndrome is observed in PREGNANT PEOPLE with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.
Drugs by status
Phase 4 trials (4)
Phase 2 trials (1)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (19)
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- Case Western Reserve University
- Federal University of Rio Grande do Sul
- Oregon Health and Science University
- RTI International
- Universidad del Valle, Colombia
- University of Tennessee
- University of Cincinnati
- University of Campinas
- Federal University of Pernambuco
- University of Sao Paulo
- Universidad del Valle de Guatemala
- Faculdade de Medicina de Botucatu
- University of Alabama, Birmingham
- Bill and Melinda Gates Foundation
- National Institute of Child Health and Human Development (NICHD)
Organization Involved with Phase 1 Indications (1)